2
Announcements
Trials
Browse
Landscape
Status
Completed
20
Unknown
7
Recruiting
6
Withdrawn
2
Terminated
2
Suspended
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Renal Insufficiency, Chronic
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Multiple Sclerosis
1
Liver Cirrhosis, Biliary
1
Irritable Bowel Syndrome
1
Inflammatory Bowel Diseases
1
Hepatitis
1
Gastritis
1
Fibrosis
1
Exocrine Pancreatic Insufficiency
1
Dyslipidemias
1
Diabetes Mellitus
1
Cystic Fibrosis
1
Crohn Disease
1
Chronic Pain
1
Chronic Disease
1
Cholelithiasis
1
Cholecystitis
1
Celiac Disease
1
Arthritis, Rheumatoid
1
Interventions
Specimen Handling
31
Magnetic Resonance Spectroscopy
19
Biopsy
16
Cyclophosphamide
15
Nivolumab
10
Paclitaxel
9
Vincristine
8
Cisplatin
8
venetoclax
7
Prednisone
7
Gemcitabine
7
Doxorubicin
7
Bevacizumab
7
Azacitidine
7
pembrolizumab
6
Radiotherapy
6
Fluorouracil
6
Etoposide
6
Drug Therapy
6
Docetaxel
6
Surgical Procedures, Operative
5
Rituximab
5
Radiosurgery
5
Oxaliplatin
5
Irinotecan
5
Injections
5
Everolimus
5
Capecitabine
5
fludarabine phosphate
4
Taxes
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Phlebotomy
×
Clear all
NCT04306939
2026-01-07
GREAT1
University of Pittsburgh
Suspended
120,000 enrolled